zoom glp 1 Are you curious about how GLP-1 weight loss drugs affect bone health? Don't miss the next Own the Bone Orthopaedic Bone Health ECHO session on August 21st happening via at 1pm GLP-1s & Healthy Lifestyle: What

Procurement fit Built for laboratories, distributors, and qualified sourcing teams comparing standalone BPC-157, repair-oriented blends, and OEM/private-label fill requirements

Sobos broader work with peptide therapy

FDA DISCLAIMER The statements on this website have not been evaluated by the U.S

Under valuation model assumptions realized through 12/31/28, the stock is modeled using: Revenue growth (CAGR): 15.9% Operating Margins: 4.5% Exit P/E Multiple: 24.7x Based on these inputs, the model estimates a target price of $33, implying 17.7% total upside from the current share price of $28 and a 6.3% annualized return over the next 2.7 years